Finance & Markets News Today — November 12, 2026

FundingWire.com brief · 22m ago · 2 min read · via FundingWire

Nvidia stock falls 7% as investors await Jensen Huang’s fate and more — today's news signal.

The financial landscape is experiencing a mix of challenges and strategic shifts, as evidenced by today's headlines. Nvidia's stock has taken a hit, falling 7% as investors anxiously await news on the fate of Jensen Huang, highlighting the tech sector's ongoing volatility. Meanwhile, consumers are bracing for increased holiday credit-card bills, prompting a search for strategies to mitigate the financial impact. This surge in expenses comes at a time when the broader economic outlook is being closely watched, particularly with the Federal Reserve expressing concern over inflation trends, with Fed's Goolsbee describing the latest inflation report as 'borderline disturbing', which may lead to further interest rate hikes.

The intersection of healthcare, finance, and policy is also making waves, with discussions around expanding Medicare coverage to more individuals, potentially benefiting workers over 50. However, not all innovative financial instruments are being met with enthusiasm, as prediction markets related to clinical trials and drug approvals are facing criticism from lawmakers. In the aviation sector, JetBlue's CEO is adopting a bullish stance, countering creditor concerns by banking on premium services to steer the company back to profitability. These developments underscore the complex and interconnected nature of finance and markets, where tech, consumer spending, healthcare, and regulatory environments all play significant roles in shaping the economic future.

Today's signal:
• Nvidia stock falls 7% as investors await Jensen Huang’s fate (cnbc.com)
• Your holiday credit-card bills are going up. What you can do to ease the pain. (marketwatch.com)
• It’s not ‘Medicare for All,’ but ‘Medicare for More.’ What this could mean for workers over 50. (marketwatch.com)
• Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire (cnbc.com)
• JetBlue's CEO has pushed back on creditor fears and is betting on premium to return to profitability (cnbc.com)
• Fed's Goolsbee calls inflation report 'borderline disturbing' as central bank weighs more hikes (cnbc.com)

Originally reported by FundingWire. FundingWire.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily finance & markets signal

More from FundingWire.com

Related ventures